CompletedNCT05869708
Official study titlePersonalizing Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia Using Clinical Biomarkers for MDD Subtypes
This study has finished and is no longer accepting participants.
In BelmontDepressionDevice studyAges 22–65
- Countries
- United States
- Sponsor
- GrayMatters Health Ltd.
CompletedNCT05894681
Official study titleBased on the Watson Model for the Prevention of Postpartum Depression Impact of Psychoeducational Intervention
This study has finished and is no longer accepting participants.
In EskişehirDepressionInterventional studyAges 20–32 weeks
- Countries
- Türkiye
- Sponsor
- Yasemin Ozhuner
CompletedNCT07273604
Official study titlePsychological Intervention in Multiple Sclerosis: Efficacy in the Treatment of Anxiety-depressive Symptoms and Cognitive Impairment.
This study has finished and is no longer accepting participants.
In San Cristóbal de La LagunaDepression, AnxietyBehavioural studyAges 18–65
- Countries
- Spain
- Sponsor
- Moisés Bermúdez Hernández
CompletedNCT04150718
Official study titleInvestigating the Role of Slow-wave Activity as a Marker of Impaired Plasticity in Major Depressive Disorder
This study has finished and is no longer accepting participants.
In PhiladelphiaDepressionBehavioural studyAges 25–50
- Countries
- United States
- Sponsor
- University of Pennsylvania
Active Not RecruitingNCT02373709
About this title
Sequence Variations of Genes in the Estrogen Pathway and Perinatal Depression
Read the official source — NCT02373709Official study titleSequence Variations of Genes in the Estrogen Pathway and Perinatal Depression
This study is no longer accepting new participants.
In SingaporeDepressionObservational studyAges 21–35
- Countries
- Singapore
- Sponsor
- KK Women's and Children's Hospital
UnknownNCT06181110
Official study titleAssociations Between Actigraphy-Derived Sleep-Wake Patterns and Illness Trajectories and Treatment Response in Major Depressive Disorder
Current recruitment status is unconfirmed.
In ShatinDepressionBehavioural studyAges 18–65
- Countries
- China
- Sponsor
- Chinese University of Hong Kong
CompletedNCT02850341
Official study titleStep Away From Depression - Evaluation of a Pedometer Intervention With Inpatients With Major Depression - A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
Multiple locations, including SalzburgDepressionDevice studyAges 18–65
- Countries
- Austria, Germany
- Sponsor
- Charite University, Berlin, Germany
CompletedNCT00607789
About this title
Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression
Read the official source — NCT00607789Official study titleA 12-Week, Double-Blind, Placebo-Controlled, Trial of Duloxetine Versus Placebo in the Treatment of Binge Eating Disorder and Comorbid Depressive Disorder.
This study has finished and is no longer accepting participants.
In CincinnatiDepression, Eating disordersMedication studyAges 18–65
- Countries
- United States
- Sponsor
- University of Cincinnati
CompletedNCT06900608
Official study titleTargeted Acceptance and Commitment Therapy Compared to Supportive Therapy for Depressive Symptoms: A Pilot Randomized Controlled Trial
This study has finished and is no longer accepting participants.
Location not clearly listedDepressionBehavioural studyAges 18+
- Countries
- Sponsor
- Western Michigan University
CompletedNCT07227753
Official study titleThe Association Between Gut Microbiota Diversity and Postpartum Depression: A Prospective Pilot Study
This study has finished and is no longer accepting participants.
In BostonDepressionObservational studyAges 18+
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT00556140
About this title
The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression
Read the official source — NCT00556140What is this study about?Researchers studied Aripiprazole, tracking side effects to assess safety and tolerability in people with depression.
This study has finished and is no longer accepting participants.
In BostonDepression, SchizophreniaMedication studyAges 18–80
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)